Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Furer

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Current Medical Research and Opinion|March 24, 2018
Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatmentDaphna Paran, Yoav Smith, Shlomo Pundak, et al.
The Journal of Rheumatology|March 16, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
Vaccine|November 27, 2019
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumabVictoria Furer, Devy Zisman, Ilana Kaufman, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
Clinical and Experimental Rheumatology|March 13, 2023
Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo studySmadar Gertel, Ari Polachek, Victoria Furer, et al.
Vaccine|October 18, 2024
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter studyTali Eviatar, Amit Ziv, Amir Oved, et al.
Vaccines|April 28, 2023
Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre StudyMerav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
RMD Open|February 25, 2021
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Nancy Agmon-Levin, et al.
The Journal of Rheumatology|January 16, 2021
Prevalence of Nonradiographic Sacroiliitis in Patients With Psoriatic Arthritis: A Real-life Observational StudyVictoria Furer, David Levartovsky, Jonathan Wollman, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Current Medical Research and Opinion|March 24, 2018
Expression levels of selected genes can predict individual rheumatoid arthritis patient response to tumor necrosis factor alpha blocker treatmentDaphna Paran, Yoav Smith, Shlomo Pundak, et al.
The Journal of Rheumatology|March 16, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
Vaccine|November 27, 2019
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumabVictoria Furer, Devy Zisman, Ilana Kaufman, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Pustular Psoriasis and Associated Musculoskeletal DisordersKristina Callis Duffin, Hervé Bachelez, Philip J Mease, et al.
Clinical and Experimental Rheumatology|March 13, 2023
Synovial monocytes from psoriatic and rheumatoid arthritis patients are modulated differently by TNF inhibitors and glucocorticoids: an ex-vivo studySmadar Gertel, Ari Polachek, Victoria Furer, et al.
Vaccine|October 18, 2024
Longitudinal safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in children aged 4-11 years with juvenile-onset autoimmune inflammatory rheumatic diseases: A prospective multicenter studyTali Eviatar, Amit Ziv, Amir Oved, et al.
Vaccines|April 28, 2023
Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre StudyMerav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, et al.
Vaccines|February 28, 2023
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up StudyTal Gazitt, Tali Eviatar, Jacqueline Shear, et al.
RMD Open|February 25, 2021
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Nancy Agmon-Levin, et al.
The Journal of Rheumatology|January 16, 2021
Prevalence of Nonradiographic Sacroiliitis in Patients With Psoriatic Arthritis: A Real-life Observational StudyVictoria Furer, David Levartovsky, Jonathan Wollman, et al.
Pageof 8